Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Mallinckrodt Pharmaceuticals is facing scrutiny over the price of its blockbuster drug Acthar
Mallinckrodt Pharmaceuticals is facing scrutiny over the price of its blockbuster drug Acthar
Mallinckrodt Pharmaceuticals is facing scrutiny over the price of its blockbuster drug Acthar
Submitted by
admin
on June 20, 2017 - 9:27am
Source:
Business Insider
News Tags:
drug pricing
Mallinckrodt
Acthar
PBMs
Express Scripts
Headline:
Mallinckrodt Pharmaceuticals is facing scrutiny over the price of its blockbuster drug Acthar
Do Not Allow Advertisers to Use My Personal information
